I'm proud to share this comprehensive executive biography, which reflects my four-decade journey in global finance, risk management, corporate governance, and leadership at EY. It's been an incredible path, shaped by collaboration, innovation, and a passion for ethical impact across borders and industries.

I’m excited to share a bit more about my professional background and the value I bring to board and advisory roles. With over 45 years of executive experience, I’m passionate about helping organizations navigate strategic challenges and seize new opportunities. Here is my biography.

I'm excited to share my updated executive biography, which reflects my journey across finance, technology, and sustainability. From leading international deals in sustainable finance to founding a blockchain-enabled ClimateFintech platform, my goal has always been to drive impact at scale.

Surya Krishnan is a seasoned finance and strategy executive with over two decades of experience in corporate development, M&A, valuation, and strategic planning. He has led over $25 billion in transactions, managed $150 million in revenue, and advised C-level executives on financial strategy and business growth. With a strong background in corporate finance, venture capital, and financial consulting, Surya has played a key role in high-profile acquisitions and investment initiatives. In addition to his leadership in corporate finance, he is committed to mentorship and professional development, guiding MBA students and emerging business leaders through financial strategy and career growth. His expertise in data-driven decision-making, market analysis, and corporate advisory continues to shape the future of finance and business strategy.

Strategic investment across technology and real estate sectors offers a balanced approach to portfolio diversification and long-term growth. By leveraging the high-risk, high-reward potential of emerging technologies like AI and PropTech alongside the stability of real estate assets, investors can optimize returns while managing risks. Venture capital and private equity play pivotal roles in this ecosystem, driving innovation in startups and scaling established businesses with operational efficiencies. With a focus on sustainability, market trends, and digital transformation, these strategic investments not only foster innovation and wealth creation but also ensure adaptability in an ever-evolving economic landscape.

Thrilled to share my professional biography, which captures the arc of my 30+ year journey across life sciences, innovation, strategy, and global health. I’ve had the honor of collaborating with visionary leaders and organizations to unlock transformative value at the intersection of science, business, and impact.

I'm excited to share my executive biography, highlighting my journey across eCommerce, strategy, and private equity. With a passion for business growth, digital transformation, and strategic execution, I am eager to leverage my experience to drive impactful change and leadership at the board level.

Michael A. Cacouris is a seasoned financial executive with over 35 years of experience in corporate finance, investment management, and restructuring. With a strong foundation in both fixed income and equity markets, he has led financial turnarounds, scaled businesses, and optimized capital structures across financial services, manufacturing, and technology startups. As a former co-CEO, hedge fund leader, and municipal finance advisor, Michael brings a unique blend of strategic vision, operational expertise, and risk management acumen to organizations seeking growth and stability. Fluent in French and Greek with international experience in Europe, he is a dynamic leader committed to driving financial and operational excellence.

Adrian Woolley is a seasoned technology executive with over 35 years of experience in business development, corporate strategy, and scaling companies in the technology and software services industries. He has a proven track record of leading business transformations, driving turnarounds, and executing strategic growth initiatives across global markets. Having played a pivotal role in multi-billion-dollar acquisitions and innovative product launches, Adrian brings deep expertise in M&A, AI, corporate strategy, and market expansion. With extensive international experience across China, Germany, the UK, and Europe, he has spoken at industry events on global strategy and technology innovation. Currently advising startups, he is now seeking board opportunities with midsized technology and software companies to leverage his leadership, strategic insight, and market expertise.

Joe Lichtenberger is a seasoned finance executive with over 30 years of experience in structured trade finance, private equity, venture capital, and corporate finance. As the Managing Principal of Crescive Capital, he leads early-stage investments, financial consulting, and capital-raising initiatives, leveraging his deep expertise in strategic growth and value creation. His career includes leadership roles at Cargill, where he structured billion-dollar financing deals and pioneered innovative investment strategies, as well as experience in private equity and investment banking at firms like The Pritzker Organization and Bear Stearns. With an MBA from Northwestern University’s Kellogg School of Management and a BBA from the University of Michigan’s Ross School of Business, Lichtenberger is recognized for his ability to navigate complex financial landscapes, optimize capital structures, and drive sustainable growth for high-impact businesses.

As a physician-scientist and biotech executive, I have dedicated my career to bridging the gap between groundbreaking medical research and commercial success. From securing multimillion-dollar funding to leading strategic M&A deals, my passion lies in driving healthcare innovation that delivers real-world impact. Here is my biography.

I’m excited to share my executive biography, which highlights my journey in revenue operations, GTM strategy, and business transformation. With over 26 years of experience helping high-growth SaaS and tech companies optimize sales processes, streamline operations, and drive revenue growth, I remain passionate about building scalable businesses and fostering operational excellence.

Greg Newbloom, CEO and founder of Membrion, Inc., is a visionary leader in clean technology with over a decade of experience driving sustainable innovation. Combining expertise in chemical engineering, business development, and strategic leadership, Greg has transformed Membrion into a market disruptor in industrial wastewater recycling, raising over $23 million and achieving commercial success. Recognized globally with honors such as the R&D 100 Award and AIChE’s 35 Under 35, Greg is dedicated to making sustainability irresistible by integrating innovation, inclusivity, and environmental impact into transformative industrial solutions.

Eric Trac is a visionary healthcare investor and biopharmaceutical strategist with a unique blend of medical expertise and financial acumen, driving transformative growth in the healthcare sector. As a Senior Analyst & Director at Sarissa Capital Management, he leads activist investment strategies, evaluates public and private market opportunities, and serves as a board director at Lyndra Therapeutics. With a background in venture capital at Vida Ventures and Vivo Capital, he has played a pivotal role in high-impact transactions, including Bayer’s $4 billion acquisition of AskBio and Centessa Pharmaceuticals’ $250 million Series A. Trac’s deep scientific foundation stems from his MD and MBA from Stanford University and his research in biotechnology at MIT, where he graduated in the top 8% of his class. Recognized as one of *Business Insider’s* “14 Most Impressive Students at MIT,” he continues to leverage his expertise in medicine and finance to drive innovation, maximize shareholder value, and advance the future of biopharmaceuticals.

Randall S. Ostler is a seasoned fintech and digital payments executive with over 30 years of experience leading product innovation, business strategy, and global operations. With a strong technical foundation and a keen understanding of business dynamics, he has successfully driven large-scale digital transformations, formed strategic international partnerships, and enhanced operational efficiencies in the financial services sector. Fluent in English, Spanish, and Portuguese, Randall has worked extensively across Asia, Europe, and Latin America, bringing a global perspective to fintech growth and innovation. His expertise in emerging payment technologies, financial compliance, and data-driven decision-making has earned him industry recognition, including multiple patents and a fintech future award. Now actively seeking board and advisory roles, he aims to leverage his cross-disciplinary expertise to help organizations navigate the complexities of digital finance and global market expansion.

Dr. Andrew S. Nevin is a globally recognized economist, strategist, and thought leader with over 40 years of experience spanning finance, economic policy, neuroscience, and corporate governance. As the Research Professor and Inaugural Director of the Brainomics™ Venture at the Center for BrainHealth, University of Texas at Dallas, he pioneers research on the economic value of brain health and its impact on productivity and human flourishing. A Rhodes Scholar with a PhD in Economics from Harvard University, Dr. Nevin has held executive leadership roles across PwC, McKinsey & Company, and United Family Hospitals, shaping global economic policies and corporate strategies. He has advised multinational corporations, financial institutions, and policymakers, particularly in Africa, where he has been instrumental in driving economic transformation and governance reforms. A prolific speaker and media contributor, he has delivered hundreds of engagements worldwide and authored influential publications on economic development, financial sustainability, and corruption. With his unique blend of academic excellence, strategic vision, and leadership experience, Dr. Nevin continues to shape the future of brain health, economic policy, and corporate innovation.